TEIKA PHARMA
TEIKA PHARMA, officially known as Teika Pharmaceutical Co., Ltd., is a prominent player in the pharmaceutical industry, headquartered in Japan (JP). Founded in 1948, the company has established itself as a leader in the development and manufacturing of high-quality pharmaceutical products, particularly in the fields of prescription medications and over-the-counter solutions. With a strong operational presence across Asia, TEIKA PHARMA is renowned for its commitment to innovation and quality. The company’s core offerings include a diverse range of therapeutic agents that address various health conditions, setting them apart through rigorous research and development processes. TEIKA PHARMA has achieved significant milestones, including numerous industry awards and recognitions, solidifying its market position as a trusted provider of healthcare solutions. With a focus on enhancing patient outcomes, TEIKA PHARMA continues to advance its mission of improving global health.
DitchCarbon Score
How does TEIKA PHARMA's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
TEIKA PHARMA's score of 3 is higher than 55% of the industry. This can give you a sense of how well the company is doing compared to its peers.
TEIKA PHARMA's reported carbon emissions
TEIKA PHARMA, headquartered in Japan, currently does not have publicly available carbon emissions data or specific reduction targets. Without concrete figures or commitments, it is challenging to assess their climate impact or initiatives. However, the pharmaceutical industry is increasingly focusing on sustainability and reducing carbon footprints. Companies are encouraged to adopt science-based targets and engage in climate pledges to mitigate their environmental impact. As TEIKA PHARMA navigates this landscape, it may consider aligning with industry standards to enhance its climate commitments in the future.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
TEIKA PHARMA is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
